Literature DB >> 1583537

Models for the binding of amiodarone to the thyroid hormone receptor.

D K Chalmers1, S L Munro, M N Iskander, D J Craik.   

Abstract

The antiarrhythmic drug amiodarone has recently been characterized as the first known thyroid hormone antagonist. Its mode of interaction with the thyroid hormone receptor is therefore of interest. A computational analysis of the conformational flexibility of amiodarone using molecular mechanics and the semiempirical molecular orbital method AM1 has been performed. The molecular mechanics studies show that the low-energy conformations of the benzoylbenzofuran portion of amiodarone can be grouped into 4 distinct classes, while the diethylaminoethoxy side chain is extremely flexible. Conformers representative of the 4 low-energy classes were fitted to an extended thyroid hormone receptor model. Four independent modes in which amiodarone could bind to the thyroid hormone receptor site were evaluated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1583537     DOI: 10.1007/bf00124384

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  10 in total

1.  A model for thyroid hormone--receptor interactions.

Authors:  T A Andrea; S W Dietrich; W J Murray; P A Kollman; E C Jorgensen; S Rothenberg
Journal:  J Med Chem       Date:  1979-03       Impact factor: 7.446

2.  Thyroid hormone analogues. Synthesis of 3'-substituted 3,5-diiodo-L-thyronines and quantitative structure-activity studies of in vitro and in vivo thyromimetic activities in rat liver and heart.

Authors:  P D Leeson; D Ellis; J C Emmett; V P Shah; G A Showell; A H Underwood
Journal:  J Med Chem       Date:  1988-01       Impact factor: 7.446

3.  Antagonism of thyroid hormone action by amiodarone in rat pituitary tumor cells.

Authors:  M F Norman; T N Lavin
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

4.  Selective thyromimetics. Cardiac-sparing thyroid hormone analogues containing 3'-arylmethyl substituents.

Authors:  P D Leeson; J C Emmett; V P Shah; G A Showell; R Novelli; H D Prain; M G Benson; D Ellis; N J Pearce; A H Underwood
Journal:  J Med Chem       Date:  1989-02       Impact factor: 7.446

5.  Amiodarone and thyroid hormone metabolism.

Authors:  W M Wiersinga; M D Trip
Journal:  Postgrad Med J       Date:  1986-10       Impact factor: 2.401

6.  Properties of amiodarone monolayer spread at the air-water interface.

Authors:  J Ferreira; R Brasseur; P Chatelain; J M Ruysschaert
Journal:  J Pharm Pharmacol       Date:  1986-08       Impact factor: 3.765

Review 7.  Thyroid hormone interactions: molecular conformation, protein binding, and hormone action.

Authors:  V Cody
Journal:  Endocr Rev       Date:  1980       Impact factor: 19.871

8.  Structure-activity relationships of antiarrhythmic agents: crystal structure of amiodarone hydrochloride and two derivatives, and their conformational comparison with thyroxine.

Authors:  V Cody; J Luft
Journal:  Acta Crystallogr B       Date:  1989-04-01

9.  Polychlorinated biphenyls and related compound interactions with specific binding sites for thyroxine in rat liver nuclear extracts.

Authors:  J McKinney; R Fannin; S Jordan; K Chae; U Rickenbacher; L Pedersen
Journal:  J Med Chem       Date:  1987-01       Impact factor: 7.446

10.  Interaction of amiodarone and desethylamiodarone with solubilized nuclear thyroid hormone receptors.

Authors:  K R Latham; D F Sellitti; R E Goldstein
Journal:  J Am Coll Cardiol       Date:  1987-04       Impact factor: 24.094

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.